Lupin bets big on India's GLP-1 market & respiratory drugs

Name: Lupin bets big on India's GLP-1 market & respiratory drugs
Uploaded: 2026-05-20T07:01:41.000Z
Duration: 2 min 14 s
Description: Lupin's Global CFO Ramesh Swaminathan says the company is seeing promising early demand in India’s GLP-1 market and plans to expand into additional geographies, while building out its respiratory and complex drug pipeline following recent FDA progress.

Lupin's Global CFO Ramesh Swaminathan says the company is seeing promising early demand in India’s GLP-1 market and plans to expand into additional geographies, while building out its respiratory and complex drug pipeline following recent FDA progress.

02:14

Wed, May 20 20263:01 AM EDT